Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-14

Clinical Trial Update: Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration [NA]

View source ↗

Summary

Clinical trial update indicating that Microcurrent Stimulation Therapy is recruiting for intermediate to advanced nonexudative age-related macular degeneration,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Microcurrent Stimulation Therapy

Snippet

Sponsor: i-Lumen Scientific AUS PTY LTD | Conditions: Age-Related Macular Degeneration, Age-related Macular Degeneration (ARMD) | NA | Status: RECRUITING